B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma
Objectivechordomas are rare bone tumors with few therapeutic options. Skull base and sacrum are the two most common origin sites. Immunotherapies are emerging as the most promising approaches to fight various cancers. This study tends to identify new cell surface targets for immunotherapeutic option...
Guardado en:
Autores principales: | Cheng Long, Gaowei Li, Chengyun Zhang, Tao Jiang, Yanjun Li, Xin Duan, Gang Zhong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5a57d5834a2c47fe85e1b1e834f5dd6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma
por: Chubei Teng, et al.
Publicado: (2021) -
Skull base chordomas review of current treatment paradigms
por: Dan Yaniv, et al.
Publicado: (2020) -
Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy
por: Andreas Köthe, et al.
Publicado: (2021) -
Gluteus maximus metastasis from sacrococcygeal chordoma: A case report
por: Wanchen Liu, MD, et al.
Publicado: (2022) -
Microscopic and Endoscopic Transoral Approaches for the Management of Craniocervical Chordomas
por: Mohammad Fathy Eissa, et al.
Publicado: (2021)